Sarda Proteins Intrinsic Value

SRDAPRT • FMCG

Sarda Proteins (SRDAPRT) median intrinsic value is ₹42.67 from 2 valuation models (range ₹17–₹43), vs current price ₹84.48 — -49.5% downside (Trading Above Calculated Value), margin of safety -98.0%. For current market price and key ratios, visit SRDAPRT stock live price.

Current Stock Price
₹84.48
Primary Intrinsic Value
₹16.90
Market Cap
₹25.3 Cr
-49.5% Downside
Median Value
₹42.67
Value Range
₹17 - ₹43
Assessment
Trading Above Calculated Value
Safety Margin
-98.0%

SRDAPRT Valuation Methods Summary — DCF, Graham Number & P/E

Sarda Proteins intrinsic value across 2 models vs current price ₹84.48 — upside/downside and value range per method. Browse SRDAPRT complete financial for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹16.90 ₹15.21 - ₹18.59 -80.0% Book Value/Share: ₹6.67, P/B: 1.0x
Revenue Multiple Method revenue ₹42.67 ₹38.40 - ₹46.94 -49.5% Revenue/Share: ₹53.33, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

SRDAPRT Intrinsic Value vs Market Price — All Valuation Models

Sarda Proteins fair value range ₹17–₹43 vs current market price ₹84.48 across 2 valuation models. Compare with SRDAPRT DCF to assess whether the stock is under or overvalued.

SRDAPRT Intrinsic Value Analysis — Undervalued or Overvalued?

Sarda Proteins median intrinsic value ₹42.67, current price ₹84.48 — Trading Above Calculated Value by 49.5%, margin of safety -98.0%.

What is the intrinsic value of SRDAPRT?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Sarda Proteins (SRDAPRT) is ₹42.67 (median value). With the current market price of ₹84.48, this represents a -49.5% variance from our estimated fair value.

The valuation range spans from ₹16.90 to ₹42.67, indicating ₹16.90 - ₹42.67.

Is SRDAPRT undervalued or overvalued?

Based on our multi-method analysis, Sarda Proteins (SRDAPRT) appears to be trading above calculated value by approximately 49.5%.

SRDAPRT Financial Health — Key Ratios vs Industry Benchmarks

Sarda Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin -11.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 5.33x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

SRDAPRT Cash Flow Quality — Operating & Free Cash Flow

Sarda Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10